Skip to content
StockMarketAgent
Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0MT8 stock hub

LON/0MT8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0MT8is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.3B
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0MT8
In the news

Latest news · LON/0MT8

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10.2
P25 12.9P50 16.9P75 23.5
Trailing P/E9.7
P25 15.9P50 22.9P75 35.8
ROE9.6
P25 -54.2P50 2.1P75 13.7
ROIC8.9
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0MT8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
222
Groups with data
11
Currency
EUR
Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Germany
Country code
UK
Employees
16,033
Employees Change
-582%
Employees Change Percent
-3.5
Enterprise value
EUR 1.4B
Exchange
London Stock Exchange
Financial currency
EUR
First seen
2026-05-10
Industry
Medical - Equipment & Services
Isin
DE0005550602
Last refreshed
2026-05-10
Market cap
EUR 1.3B
Price
EUR 72.8
Price currency
EUR
Rev Per Employee
191,022.92x
Sector
Healthcare
Sic
3841
Symbol
lon/0MT8
Website
https://www.draeger.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
10.26%
EV Earnings
10.23x
EV/EBIT
6.71x
EV/EBITDA
4.48x
EV/FCF
9.69x
EV/Sales
0.45x
FCF yield
10.84%
Forward P/E
10.19x
P/B ratio
0.9x
P/E ratio
9.75x
P/S ratio
0.43x
PE Ratio10 Y
17.98x
PE Ratio3 Y
9.4x
PE Ratio5 Y
10.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
6.71%
EBITDA Margin
8.68%
FCF margin
4.61%
Gross margin
45.32%
Gross Profit
EUR 1.4B
Gross Profit Growth
5.03%
Gross Profit Growth Q
4.55%
Gross Profit Growth3 Y
6.75%
Gross Profit Growth5 Y
-1.78%
Net Income
EUR 133.6M
Net Income Growth
32.79%
Net Income Growth Quarters
3%
Net Income Growth Years
3%
Net Income Growth5 Y
-11.24%
Pretax Margin
6.68%
Profit Margin
4.36%
Profit Per Employee
EUR 8,334
Profitable Years
3
ROA
4.72
Roa5y
2.89
ROCE
10.48
ROE
9.63
Roe5y
6.81
ROIC
8.86
Roic5y
7.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

23
MetricValue
Cagr10y
4.08%
Cagr15y
3.72%
Cagr1y
47.27%
Cagr3y
24.87%
Cagr5y
1.21%
Div CAGR10
5.39%
Div CAGR3
146.11%
Div CAGR5
69.54%
EPS Growth Quarters
3
EPS Growth Years
3
FCF Growth
25.04%
FCF Growth Q
-11.27%
FCF Growth5 Y
-15.05%
OCF Growth
28.85%
OCF Growth Q
10.88%
OCF Growth10 Y
8.04%
OCF Growth5 Y
-12.87%
Revenue Growth
4.23x
Revenue Growth Q
3.51x
Revenue Growth Quarters
3x
Revenue Growth Years
1x
Revenue Growth3 Y
3.57x
Revenue Growth5 Y
-0.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 1.13
Assets
EUR 2.8B
Cash
EUR 235M
Current Assets
EUR 1.7B
Current Liabilities
EUR 797.3M
Debt
EUR 298.8M
Debt EBITDA
EUR 0.97
Debt Equity
EUR 0.21
Debt FCF
EUR 2.12
Equity
EUR 1.4B
Interest Coverage
11.72
Liabilities
EUR 1.3B
Long Term Assets
EUR 1.1B
Long Term Liabilities
EUR 520.9M
Net Cash
EUR -63.9M
Net Cash By Market Cap
EUR -4.9
Net Debt EBITDA
EUR 0.24
Net Debt Equity
EUR 0.04
Net Debt FCF
EUR 0.45
Tangible Book Value
EUR 1.2B
WACC
6.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.07
Inventory Turnover
2.72
Net Working Capital
EUR 651.7M
Quick ratio
1.17
Working Capital
EUR 865M
Working Capital Turnover
EUR 3.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Dividend Growth
10.68%
Dividend Growth Years
3%
Dividend per share
EUR 1.66
Dividend Years
15
Dividend Yield
2.28%
Ex Div Date
2025-05-12
Last Dividend
EUR 1.66
Payout Frequency
Annual
Payout Ratio
24.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
49.21%
1Y total return
47.24%
200-day SMA
62.78
3Y total return
94.75%
50-day SMA
71.64
50-day SMA vs 200-day SMA
50over200
5Y total return
6.22%
All Time High
88
All Time High Change
-17.27%
All Time High Date
2013-05-17
All Time Low
32.2
All Time Low Change
126.09%
All Time Low Date
2019-09-30
ATR
2.18
Beta
0.61
Ch YTD
25.95
High
72.8
High52
77.4
High52 Date
2026-04-13
High52ch
-5.94%
Low
71.8
Low52
48.7
Low52 Date
2025-05-12
Low52ch
49.49%
Ma50ch
1.62%
Price vs 200-day SMA
15.96%
RSI
51.99
RSI Monthly
65.87
RSI Weekly
59.4
Sharpe ratio
1.08x
Sortino ratio
1.82
Total Return
2.28%
Tr YTD
25.95
Tr15y
73.06%
Tr1m
-1.09%
Tr1w
3.41%
Tr3m
4.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
EUR 205.4M
Operating Income Growth
57.66
Operating Income Growth Q
1,968.3
Operating Income Growth5 Y
-14.9
Operating margin
6.71

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

4
MetricValue
Float
10,574,088%
Net Borrowing
-91,116,382.8
Shares Insiders
32.65%
Shares Institutions
18.67%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
EUR 141.2M
Average Volume
88.8x
CAPEX
EUR -72.2M
Ch10y
34.68
Ch15y
45.73
Ch1m
-1.09
Ch1w
3.41
Ch1y
41.63
Ch3m
4.3
Ch3y
79.31
Ch5y
-2.67
Ch6m
24.23
Change
-1.89%
Change From Open
0.28
Close
74.2
Days Gap
-2.16
Depreciation Amortization
59,960,536.5
Dollar Volume
7,644
Earnings Date
2026-04-30
EBIT
EUR 205.4M
EBITDA
EUR 266M
F Score
7
FCF
EUR 141.2M
FCF EV Yield
10.32x
Financing CF
-114,254,997
Fiscal Year End
December
Founded
1,889
Graham Number
116.54458
Graham Upside
60.09
Income Tax
EUR 70.4M
Investing CF
-80,467,476
Is Primary Listing
0
Last Earnings Date
2026-04-30
Last Report Date
2026-03-31
Lynch Fair Value
EUR 37.34
Lynch Upside
-48.71
Ma150
64.84
Ma150ch
12.27%
Ma20
73.08
Ma20ch
-0.38%
Net CF
17,030,412
Next Earnings Date
2026-07-30
Open
72.6
P FCF Ratio
9.23
P OCF Ratio
6.1
Payment Date
2025-05-14
Position In Range
100
Ppne
484,177,266.3
Price Date
2026-05-08
Price EBITDA
EUR 4.9
Ptbv Ratio
1.13
Relative Volume
1.18x
Revenue
3,062,670,476x
Tax By Revenue
2.3x
Tax Rate
34.45%
Tr6m
24.23%
Volume
105
Z Score
2.81
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

LON/0MT8 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.3%
$1.66 annual per share
Payout ratio
+24.5%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+69.5%
3 consecutive years of growth
Total shareholder yield
+2.3%
Next ex-dividend date: 2025-05-12
Performance

LON/0MT8 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+47.2%
S&P 500 1Y: n/a
3Y total return
+94.8%
S&P 500 3Y: n/a
5Y total return
+6.2%
S&P 500 5Y: n/a
10Y total return
+49.2%
S&P 500 10Y: n/a
Ownership

Who owns LON/0MT8?

Insider, institutional, and short-interest positioning.

Institutional ownership
+18.7%
Share of float held by funds and institutions
Insider ownership
+32.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

LON/0MT8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
52.0
Neutral momentum band
Price vs 200-day MA
+16.0%
50/200-day relationship not available
Beta (5Y)
0.61
Less volatile than the market
Sharpe ratio
1.08
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0MT8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0MT8 stock rating?

lon/0MT8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0MT8 analysis?

The full report lives at /stocks/lon/0MT8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0MT8?

The latest report frames lon/0MT8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0MT8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.